Company Directory / Medical Device
Public · NASDAQ:NVCNFor profitMedical DeviceRichmond, B.C., Canada
Neovasc
Neovasc Inc. is a specialty medical device company that develops and manufactures products for the rapidly growing.
- Founded
- 2000 26 years ago
- Staff
- 51-100 29 on LinkedIn
- Followers
- 8k on LinkedIn
- Funding
- $385M as listed, USD
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer™ for the treatment of refractory angina and the Tiara™ technology in development for the transcatheter treatment of mitral valve disease. To receive Neovasc updates via email, please register at: http://www.neovasc.com/register.
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed. 29 people list it on LinkedIn.
Age
26 years old.
Reach
Website ranked #10,134,952 in the world for traffic, about 254 visits a month. 7,996 followers on LinkedIn.
What it does
HardwareManufacturingtranscatheter heart valvesRefractory AnginaReducer DeviceTiara Mitral Valves
Funding, as listed
$385M raised in total
- Rounds15
- LatestPost ipo equity, Feb 2021
- Latest amountUSD 72,000,000
- Investors2, 2 leading
What the source datasets report. We have not watched these rounds ourselves, and do not hold this company in the startups database.
Every detail we hold
Everything the source datasets list about Neovasc, field by field. Contact details are held but never shown.
The company
- Name
- Neovasc
- Type
- For profit
- Status
- Public · NASDAQ:NVCN
- Founded
- 2000
- Founders
- Alexei Marko
- Industry
- Medical Device
- Categories
- Hardware, Manufacturing
- Specialities
- transcatheter heart valves, Refractory Angina, Reducer Device, Tiara Mitral Valves
Where
- City
- Richmond
- Region
- B.C.
- Country
- Canada
- Markets
- Great Lakes
Size and reach
- Staff band
- 51-100
- People on LinkedIn
- 29
- LinkedIn followers
- 7,996
- Web traffic rank
- #10,134,952
- Monthly web visits
- 254
Funding, as listed
- Total
- $385,151,711 USD
- Rounds
- 15
- Latest round
- Post ipo equity
- Latest round date
- Feb 2021
- Latest amount
- 72,000,000 USD
- Investors
- 2
- Lead investors
- 2
- Stock listing
- NASDAQ:NVCN
- Listing status
- public
About this record
- Sources
- Crunchbase, LinkedIn
- Last imported
- Sept 2026
Growth, as the source summarises it
Neovasc may be growing as indicated by the acquisition of its Reducer System by Shockwave Medical, which suggests a positive development for the company's product portfolio. The Reducer System is currently in trials for patients with coronary obstructive refractory angina, demonstrating ongoing clinical research and potential for market expansion. Furthermore, Neovasc is mentioned in the context of the pericardial patches market, which is expected to reach significant revenue, indicating that the company operates in a growing market segment.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
Medical Device in Canada.
KardiumBurnaby · 101-250 people · 15k followers
Venus ConceptToronto · 251-500 people · 55k followers
Lungpacer MedicalVancouver · 51-100 people · 3k followers
Synaptive MedicalToronto · 101-250 people · 29k followers
Cloud DXKitchener · 11-50 people · 4k followersOOptina DiagnosticsMontréal · 11-50 people · 5k followersFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 136,547 companies in Canada and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.